NCT06202027View on ClinicalTrials.gov

Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 11, 2023

Primary Completion Date

June 16, 2031

Study Completion Date

July 16, 2031

Conditions
FGF23-related Hypophosphataemic Rickets and Osteomalacia
Interventions
DRUG

FGF23-related hypophosphataemic rickets and osteomalacia

FGF23-related hypophosphataemic rickets and osteomalacia

Trial Locations (13)

16499

RECRUITING

Ajou University Hospital, Suwon

26426

RECRUITING

Wonju Severance Christian Hospital, Wŏnju

30099

RECRUITING

Chungnam National University Sejong Hospital, Sejong

47392

RECRUITING

Inje University Busan Paik Hospital, Busan

49241

RECRUITING

Pusan National University Hospital, Busan

50612

RECRUITING

Yangsan Pusan National University Hospital, Yangsan

61469

RECRUITING

Chonnam National University Hospital, Gwangju

03080

RECRUITING

Seoul National University Hospital, Seoul

RECRUITING

Seoul National University Hospital, Seoul

RECRUITING

Seoul National University Hospital, Seoul

03722

RECRUITING

Severance Hospital, Seoul

RECRUITING

Severance Hospital, Seoul

08308

RECRUITING

Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

Kyowa Kirin Korea Co., Ltd.

INDUSTRY